Silvercrest Asset Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-491,318
Closed -$20.3M 576
2016
Q3
$20.3M Sell
491,318
-450,630
-48% -$18.9M 0.24% 120
2016
Q2
$37.6M Sell
941,948
-426,286
-31% -$15.3M 0.48% 87
2016
Q1
$46.1M Buy
1,368,234
+39,228
+3% +$1.22M 0.63% 66
2015
Q4
$45M Buy
1,329,006
+40,236
+3% +$1.26M 0.62% 61
2015
Q3
$38.4M Sell
1,288,770
-202,223
-14% -$6.32M 0.58% 71
2015
Q2
$41.1M Sell
1,490,993
-77,942
-5% -$2.08M 0.55% 69
2015
Q1
$39.5M Buy
1,568,935
+62,691
+4% +$1.48M 0.56% 67
2014
Q4
$33.4M Buy
1,506,244
+3,506
+0.2% +$71.1K 0.48% 78
2014
Q3
$30.5M Buy
1,502,738
+6,620
+0.4% +$132K 0.47% 78
2014
Q2
$28.8M Buy
1,496,118
+184,320
+14% +$3.43M 0.43% 89
2014
Q1
$24.7M Buy
1,311,798
+239,289
+22% +$4.62M 0.39% 94
2013
Q4
$20.9M Buy
1,072,509
+261,998
+32% +$4.81M 0.35% 101
2013
Q3
$13.3M Buy
810,511
+98,345
+14% +$1.58M 0.26% 113
2013
Q2
$10.7M Buy
+712,166
New +$10.4M 0.23% 118

Other funds holding IART

Silvercrest Asset Management's IART Position: Q4 2016 in Review

Silvercrest Asset Management sold out of Integra LifeSciences (IART) in Q4 2016, closing a stake of 491,318 shares — an estimated $20.3M sold.

Silvercrest Asset Management first reported a position in IART in Q2 2013 and held it in 14 quarters. The position peaked at $46.1M in Q1 2016. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.

  • Silvercrest Asset Management reported no remaining Integra LifeSciences position as of Q4 2016 after selling out during the quarter.
  • Silvercrest Asset Management sold 491,318 Integra LifeSciences shares in Q4 2016, an estimated $20.3M.
  • Silvercrest Asset Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 14 quarters.
  • Silvercrest Asset Management's Integra LifeSciences position peaked at $46.1M in Q1 2016.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on Silvercrest Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.